Meclonazepam CAS: 58662-84-3

CAS NO: 58662-84-3
Meclonazepam
Chemical Name: Meclonazepam
Molecular Formula: C16H12ClN3O3
Formula Weight: 329.74
CAS No.: 58662-84-3
Description Review
Description

Meclonazepam is a psychoactive drug in the benzodiazepine class. It is a structural analog of clonazepam and belongs to a group of drugs commonly known as "designer benzodiazepines." Meclonazepam was first synthesized in the 1970s and is still available in some countries. The chemical name of meclonazepam is 3-Methylclonazepam, and it has the molecular formula C16H12ClN3O2, with a formula weight of 319.74 g/mol. The CAS number of meclonazepam is 58662-84-3.

Top Ten Keywords and Synonyms

  1. Designer benzodiazepine
  2. Psychoactive drug
  3. Clonazepam analog
  4. Benzodiazepine derivative
  5. Recreational drug
  6. Anxiolytic medication
  7. Sedative
  8. Prescription drug abuse
  9. Synthetic drug
  10. Depressant

Health Benefits of Meclonazepam

Meclonazepam can be beneficial for the treatment of anxiety disorders, panic attacks, and insomnia. It works by increasing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that helps regulate brain activity. This leads to a calming effect on the brain and nervous system, making it easier for individuals to fall asleep and stay asleep. Meclonazepam can be an effective option for patients who experience difficulty in sleeping for prolonged periods, have panic attacks or anxiety disorders.

Potential Effects of Meclonazepam

The effects of meclonazepam are similar to those of other benzodiazepines. The drug induces a calming effect on the central nervous system, leading to sedation, relaxation, and a reduction in anxiety levels. It also has muscle relaxant and anticonvulsant properties, which can be helpful in treating conditions such as epilepsy or spasms. It can cause drowsiness, reduced alertness and responsiveness, and lack of coordination. Meclonazepam has a high potential for abuse and dependence, and long-term use can lead to tolerance, dependence, and addiction.

Product Mechanism

As with other benzodiazepines, the mechanism of action of meclonazepam is related to GABAergic neurotransmission. Meclonazepam enhances the binding of GABA to specific receptors in the brain, which leads to an increase in the activity of GABA. This activity inhibits neuronal activity and brain activity, leading to a calming effect, relaxation, and a reduction in anxiety levels. The effect of meclonazepam on GABA neurotransmitters can lead to widespread inhibition in the central nervous system, which explains the range of effects the drug can produce.

Safety of Meclonazepam

Meclonazepam is a prescription medication and should only be taken under the supervision of a physician or toxicologist. It is classified as a Schedule IV drug by the United States Drug Enforcement Administration (DEA), which means that it has a low potential for abuse and dependence when compared to Schedule I, II, and III drugs, but still poses some risk of addiction. Individuals who are hypersensitive to benzodiazepines or have a history of substance abuse should not take meclonazepam. It is important to follow dosing instructions carefully and to avoid taking the drug with alcohol or other CNS depressants.

Side Effects of Meclonazepam

The most common side effects of meclonazepam are drowsiness, dizziness, and lack of coordination. Other side effects may include confusion, memory impairment, headache, nausea, constipation, and dry mouth. Meclonazepam is also known to cause sedation and reduced alertness, which can lead to impairments in judgment and response time. In rare cases, meclonazepam can cause paradoxical reactions, agitation, and suicidal thoughts. Overdose can cause respiratory depression, coma, and even death.

Dosing Information

Meclonazepam should be taken as instructed by a healthcare provider. The recommended dose varies depending on the individual's age, weight, and other factors. It is typically taken orally, with or without food, and should not be crushed, chewed, or broken. The drug should not be taken for longer than prescribed, and discontinuation should be done gradually to avoid withdrawal symptoms.

Conclusion

Meclonazepam is a psychoactive drug that belongs to a group of designer benzodiazepines. It is used for the treatment of anxiety disorders, panic attacks and insomnia. As with other benzodiazepines, the drug acts as a central nervous system depressant that enhances the activity of GABA neurotransmitters in the brain leading to sedation, relaxation, and a reduction in anxiety levels. It is important to follow dosing instructions carefully and only take meclonazepam under the guidance of a healthcare provider. Individuals who have a history of substance abuse, hypersensitivity to benzodiazepines or have shown an addiction tendency, should not take this drug.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code